Medigraph Pharmaceuticals Private Limited, a active private limited company, was established on 10 March 1995 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239MH1995PTC086316. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.40 M.
It upholds a compliant status. Employing 2 professional, Its leadership includes Pranay Ramniwas Goel (Director), Pankaj Ravindra Chaudhari (Director). Past directors included Manohar Ramchandra Mulye, Shankar Narayan Iyer, Srivathsan Krishamur Iyer. It holds ₹2.31 Cr open charges and ₹2.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 301 Eric House16Th Road Chembur, Mumbai, Maharashtra, 400071.
U24239MH1995PTC086316
086316
10 March 1995
₹2.50 M
₹2.40 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Medigraph Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pranay Ramniwas Goel | Director | 10 Mar 1995 | Current |
| Pankaj Ravindra Chaudhari | Director | 08 Dec 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Jun 2008 | Past |
| Pramod Abcsdd | Director | 31 Aug 2011 | Past |
| Pramod Abcsdd | Director | 03 Oct 2014 | Past |
| Pramod Abcsdd | Director | 01 Oct 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medigraph Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.95% decrease. The company also saw a substantial fall in profitability, with a 67.06% decrease in profit. The company's net worth Soared by an impressive increase of 10.98%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Medigraph Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹23,074,681.00
₹25,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2024 | Hdfc Bank Limited | ₹3.07 M | Open |
| 03 Dec 2022 | Hdfc Bank Limited | ₹2.00 Cr | Open |
| 07 Nov 2020 | Hdfc Bank Limited | ₹2.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Medigraph Pharmaceuticals has a workforce of 2 employees as of Oct 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medigraph Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medigraph Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Medigraph Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge with Hdfc Bank Limited of Rs. 20.00 M registered on 03 Dec 2022 with Charge ID 100661065 was modified on 11 Jun 2024. was recorded as a recent event.
The activity Medigraph Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 3.07 M with Charge ID 100912435 was registered on 28 Feb 2024. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 20.00 M with Charge ID 100661065 was registered on 03 Dec 2022. was recorded as a recent event.
The activity A charge registered on 07 Nov 2020 via Charge ID 100419990 with Hdfc Bank Limited was fully satisfied on 02 Aug 2022. was completed.
The CIN of Medigraph Pharmaceuticals Private Limited is U24239MH1995PTC086316.
Medigraph Pharmaceuticals Private Limited is headquartered at 301 Eric House16Th Road Chembur, Mumbai, Maharashtra, 400071.
Medigraph Pharmaceuticals Private Limited was incorporated on 10 March 1995.
The current directors of Medigraph Pharmaceuticals Private Limited are
The primary industry of Medigraph Pharmaceuticals Private Limited is Manufacturing.
Medigraph Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medigraph Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹2.40 M.
The compliance status of Medigraph Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX